NYSEARCA:PFNX - NYSE Arca -
Mentions: LGND
NEW YORK, NY / ACCESSWIRE / September 16, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Otelco Inc. (NASDAQ:OTEL) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to affiliates formed by Oak Hill Capital for $11.75 per share. To learn more about your legal rights and options, visit:
NEW YORK, NY / ACCESSWIRE / September 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Builders FirstSource, Inc. (NASDAQ:BLDR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with BMC Stock Holdings, Inc. Under the terms of the agreement, BMC shareholders will receive 1.3125 shares of Builders FirstSource common stock for
The Techncial Trigger Driven Option Trade Right Before Pfenex Inc (ASE:PFNX) Earnings.
Mentions: BMY
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - DCOM, OTEL, PFNX, MR NEW YORK, NY / ACCESSWIRE / September 3, 2020 /Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: Dime Community Bancshares, Inc. (NASDAQ:DCOM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger
NEW YORK, NY / ACCESSWIRE / September 1, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sanofi for $100 per share. To learn more about your legal rights and options, visit:
Mentions: PRNB
Mentions: LGND
NEW YORK, NY / ACCESSWIRE / August 29, 2020 /Halper Sadeh LLP, a global investor rights law firm, continues to investigate: National General Holdings Corp. (NASDAQ:NGHC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to The Allstate Corporation for $34.50 per share. Under the terms of the proposed transaction, National General shareholders will receive $32.00 per share
Legion Partners revealed that it owns 2,904,340 shares of Landec, a maker of packaged foods and biomaterials, and Engaged Capital initiated a 9.99% stake in health-care-services firm Evolent, equal to 8,553,155 shares.
NEW YORK, NY / ACCESSWIRE / August 25, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: National General Holdings Corp. (NASDAQ: NGHC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to The Allstate Corporation for $34.50 per share. Under the terms of the proposed transaction, National General shareholders will receive $32.00
NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: National General Holdings Corp. (NASDAQ:NGHC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to The Allstate Corporation for $34.50 per share. Under the terms of the proposed transaction, National General shareholders will receive $32.00 per share in
NEW YORK, NY / ACCESSWIRE / August 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Pfenex Inc. (NYSE:PFNX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Ligand Pharmaceuticals Incorporated. Under the terms of the merger agreement, Pfenex shareholders will receive $12.00 per share in cash. In addition, Ligand will pay Pfenex
NEW YORK, NY / ACCESSWIRE / August 14, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Varian Medical Systems, Inc. (NYSE: VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siemens Healthineers AG for $177.50 per share. To learn more about your legal rights and options, visit:
Mentions: LGND
There’s a lot of amazing developments in the health care space right now, but are investors bullish on these 2 top health care stocks right now?
Mentions: PRPH
Gainers Kelly Services, Inc. (NASDAQ: KELYB) shares jumped 118.3% to close at $38.21 on Tuesday. Kelly Services released Q2 earnings last week. Pfenex Inc. (NYSE: PFNX) shares...
Toward the end of trading Tuesday, the Dow traded up 1.06% to 28085.22 while the NASDAQ fell 0.22% to 10,944.77. The S&P also rose, gaining 0.45% to 3,375.46. The U.S. has the...
Gainers: Biofrontera (NASDAQ:BFRA) +75%.Pfenex (NYSEMKT:PFNX) +66%.Oxbridge Re (NASDAQ:OXBR) +60%.Sypris Solutions (NASDAQ:SYPR) +47%.Eyenovia (NASDAQ:EYEN) +42%.ProPhase Labs (NASDAQ:PRPH) +39%.Kforce (NASDAQ:KFRC) +29%.Calyxt (NASDAQ:CLXT) +27%.American Public Education (NASDAQ:APEI) +20%.Hallmark Financial Services (NASDAQ:HALL) +18%.Losers: Fulcrum Therapeutics (NASDAQ:FULC) -45%.Fennec Pharmaceuticals (NASDAQ:FENC) -35%.Mesoblast (NASDAQ:MESO) -33%.Sunworks (NASDAQ:SUNW) -30%.Genesis Healthcare (NYSE:GEN) -26%.PDS Biotechnology (NASDAQ:PDSB) -24%.Ideanomics (NASDAQ:IDEX) -23%.Pixelworks (NASDAQ:PXLW) -23%.Precigen (NASDAQ:PGEN) -22%.GreenSky (NASDAQ:GSKY) -21%.
NEW YORK, NY / ACCESSWIRE / August 11, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Pfenex Inc. (NYSE:PFNX) to Ligand Pharmaceuticals Incorporated is fair to Pfenex shareholders. Under the terms of the merger agreement, Pfenex shareholders will receive $12.00 per share in cash. In addition, Ligand will pay Pfenex shareholders $2.00 per share as a Contingent Value Right in the event a predefined
Gainers: Pfenex (NYSEMKT:PFNX) +67%. Eyenovia (NASDAQ:EYEN) +44%.
Investors need to pay close attention to Pfenex (PFNX) stock based on the movements in the options market lately.
Oxbridge Re Holdings (NASDAQ:OXBR) +112% on Q2 results.Pfenex (NYSEMKT:PFNX) +63% on being acquired by Ligand.Immutep (NASDAQ:IMMP) +24% on granting US patent for Eftilagimod Alpha in Chemo-Immunotherapy combination.The Peck (NASDAQ:PECK) +27% on Q2 results.Equillium (NASDAQ:EQ) +19% on announcing positive interim data with Itolizumab in Acute GVHD Study.Sypris Solutions (NASDAQ:SYPR) +10% on contract win.LendingClub (NYSE:LC) +18%.the Rubicon Project (NASDAQ:MGNI) +17% on Q2 results.RCI Hospitality (NASDAQ:RICK) +13% on Q2 results.Nautilus (NYSE:NLS) +13% on Q2 results.Mesa Air (NASDAQ:MESA) +13% on Q3 results.Protalix BioTherapeutics (NYSEMKT:PLX) +12% as FDA accepts Protalix application for enzyme replacement therapy for Fabry.Seres Therapeutics (NASDAQ:MCRB) +10%.Norwegian Cruise Line (NYSE:NCLH) +10%.Fortress Biotech (NASDAQ:FBIO) +10% on Q2 results.GreenSky (NASDAQ:GSKY) +11% on Q2 results.Hersha Hospitality Trust (NYSE:HT) +9%.NIO (NYSE:NIO) +9%.